| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Nalcn - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN510717 | 1 kit | ORIGENE TECHNOLOGIES |
| N(alpha)-acetyltransferase 16, NatA auxiliary subunit (NAA16), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403001 | 100 ug | ORIGENE TECHNOLOGIES |
| N(alpha)-acetyltransferase 10, NatA catalytic subunit (NAA10) from ORIGENE TECHNOLOGIES | LY401179 | 100 ug | ORIGENE TECHNOLOGIES |
| Human myoglobin (MB), transcript variant 1 from ORIGENE TECHNOLOGIES | TP312352 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Myoglobin ELISA kit from ORIGENE TECHNOLOGIES | EA101009 | 96-well strip plate | ORIGENE TECHNOLOGIES |
| Human myoglobin (MB), transcript variant 3 from ORIGENE TECHNOLOGIES | TP303113 | 20 ug | ORIGENE TECHNOLOGIES |
| Human myo-inositol oxygenase (MIOX) from ORIGENE TECHNOLOGIES | TP310070 | 20 ug | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenocarcinoma of endometrium, endometrioid from ORIGENE TECHNOLOGIES | CS500491 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenocarcinoma of endometrium, endometrioid, squamous features from ORIGENE TECHNOLOGIES | CS800033 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenocarcinoma of endometrium, endometrioid, squamous features from ORIGENE TECHNOLOGIES | CS600102 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenocarcinoma of endometrium, serous from ORIGENE TECHNOLOGIES | CS800652 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenomyosis of myometrium from ORIGENE TECHNOLOGIES | CS800228 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenomyosis of myometrium from ORIGENE TECHNOLOGIES | CS804946 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenomyosis of myometrium from ORIGENE TECHNOLOGIES | CS806711 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenomyosis of myometrium from ORIGENE TECHNOLOGIES | CS600601 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Adenomyosis of myometrium from ORIGENE TECHNOLOGIES | CS600602 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma, atypical from ORIGENE TECHNOLOGIES | CS700663 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma, atypical from ORIGENE TECHNOLOGIES | CS700664 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma, atypical from ORIGENE TECHNOLOGIES | CS502208 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma, atypical from ORIGENE TECHNOLOGIES | CS502209 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700018 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700019 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700034 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700035 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700064 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700065 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700084 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Myometrium; Leiomyoma of myometrium from ORIGENE TECHNOLOGIES | CS700088 | 5x5um | ORIGENE TECHNOLOGIES |
| Ucn3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518647 | 1 kit | ORIGENE TECHNOLOGIES |
| UCP2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN403997 | 1 kit | ORIGENE TECHNOLOGIES |
| UCP3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416165 | 1 kit | ORIGENE TECHNOLOGIES |
| UCP1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418901 | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518648 | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518649 | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN518650 | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN318648 | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN318648BN | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN318648LP | 1 kit | ORIGENE TECHNOLOGIES |
| Ucp1 - mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN318648RB | 1 kit | ORIGENE TECHNOLOGIES |
| UDP-galactose-4-epimerase (GALE), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424739 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-galactose-4-epimerase (GALE), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423394 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-galactose-4-epimerase (GALE), transcript variant 3 from ORIGENE TECHNOLOGIES | LY426826 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 1 (B3GALT1) from ORIGENE TECHNOLOGIES | LY412159 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 2 (B3GALT2) from ORIGENE TECHNOLOGIES | LY401245 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 4 (B3GALT4) from ORIGENE TECHNOLOGIES | LY418438 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 1 (B4GALT1) from ORIGENE TECHNOLOGIES | LY400575 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 3 (B4GALT3) from ORIGENE TECHNOLOGIES | LY401244 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 4- galactosyltransferase, polypeptide 5 (B4GALT5) from ORIGENE TECHNOLOGIES | LY417757 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416890 | 100 ug | ORIGENE TECHNOLOGIES |
| UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase, polypeptide 5 (B3GALT5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY409690 | 100 ug | ORIGENE TECHNOLOGIES |